Scott Centea - 19 Jul 2023 Form 4/A - Amendment Insider Report for ANGIODYNAMICS INC (ANGO)

Role
SVP/GM, VIT
Signature
/s/ Stephen A. Trowbridge, Attorney in Fact
Issuer symbol
ANGO
Transactions as of
19 Jul 2023
Net transactions value
-$24,227
Form type
4/A - Amendment
Filing time
21 Sep 2023, 21:17:23 UTC
Date Of Original Report
26 Jul 2023
Previous filing
18 Jul 2023
Next filing
25 Jul 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANGO Common Stock Options Exercise $0 +7,539 +13% $0.000000 65,667 19 Jul 2023 Direct F1
transaction ANGO Common Stock Tax liability $24,227 -2,716 -4.1% $8.92 62,951 19 Jul 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANGO Performance Right Options Exercise $0 -11,782 -100% $0.000000* 0 19 Jul 2023 Common Stock 11,782 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This acquisition of 7,539 shares of Common Stock ("Common Stock") of AngioDynamics, Inc. ("AngioDynamics") represents shares acquired through the vesting and settlement of performance share units granted to the reporting person on July 14, 2020.
F2 The exempt disposition of 2,716 shares of Common Stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying performance share units granted to the reporting person on July 14, 2020.
F3 On July 14, 2020, the reporting person received a target grant of 11,782 performance share units. Between 0% and 200% of the target number was to be earned based on achievement of pre-determined performance metrics for fiscal years 2021, 2022 and 2023. In addition, 20% of the total shares earned could be awarded (or cancelled) based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics as determined by the compensation committee. Based on performance over the period, 7,539 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited.

Remarks:

This Form 4/A is being filed to correct the number of shares received by the Reporting Person and subsequently sold to satisfy tax withholding obligations in connection with the vesting and settlement of performance share units on 07/19/2023 and provides corrected amounts in Columns 4 and 5 of Table I.